enteric vasculature. Radiol Clin North Am 2002;40:867-86.
67. Chow LC, Chan FP, Li KC. A comprehensive approach to MR
imaging of mesenteric ischemia. Abdom Imaging 2002;27:
507-16.
68. Shih MC, Angle JF, Leung DA, Cherry KJ, Harthun NL,
Matsumoto AH, et al. CTA and MRA in mesenteric ischemia:
part 2, Normal Ô¨Åndings and complications after surgical
and endovascular treatment. AJR Am J Roentgenol
2007;188:462-71.
69. Baden JG, Racy DJ, Grist TM. Contrast-enhanced threedimensional magnetic resonance angiography of the
mesenteric vasculature. J Magn Reson Imaging 1999;10:
369-75.
70. Meaney JF, Prince MR, Nostrant TT, Stanley JC. Gadoliniumenhanced MR angiography of visceral arteries in patients
with suspected chronic mesenteric ischemia. J Magn
Reson Imaging 1997;7:171-6.
71. Carlos RC, Stanley JC, Stafford-Johnson D, Prince MR.
Interobserver variability in the evaluation of chronic

mesenteric ischemia with gadolinium-enhanced MR
angiography. Acad Radiol 2001;8:879-87.
72. Fraum TJ, Ludwig DR, Bashir MR, Fowler KJ. Gadoliniumbased contrast agents: A comprehensive risk assessment.
J Magn Reson Imaging 2017;46:338-53.
73. Balduf LM, Langsfeld M, Marek JM, Tullis MJ, Kasirajan K,
Matteson B. Complication rates of diagnostic angiography
performed by vascular surgeons. Vasc Endovasc Surg
2002;36:439-45.
74. Waugh JR, Sacharias N. Arteriographic complications in the
DSA era. Radiology 1992;182:243-6.
